tradmap

ARGX Argenx Se

$877.69 -1.67%

Healthcare · Biological Products, (No Diagnostic Substances)

Argenx Se (ARGX) is a healthcare company in the Biological Products, (No Diagnostic Substances) industry. Shares last traded at $877.69, 6.0% below their 52-week high. Over the past year the stock is up 62.4%.

Market Cap
Shares Out
EPS (TTM)
P/E Ratio
P/S Ratio
P/B Ratio
Dividend / Share
Dividend Yield
52-Week High
$934.14
52-Week Low
$510.10
Volume
24,053
Avg Vol (3m)
27,315.937

Performance

1W
-2.33%
1M
+9.93%
3M
+28.28%
6M
+3.17%
YTD
+4.48%
1Y
+62.42%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
57.76
SMA (50)
$822.71
SMA (200)
$811.28
Price vs SMA50
+6.68%
Price vs SMA200
+8.19%
ATR (14)
$25.96

Financials

Revenue
Net Income
$-163M
Gross Margin
Operating Margin
Net Margin
Return on Equity
Return on Assets
Current Ratio
Debt / Equity
Revenue Growth (YoY)

Biological Products, (No Diagnostic Substances) peers

ARGX vs 14 industry peers (Biological Products, (No Diagnostic Substances)), by market cap.

1–14 of 14
AMGNAmgen$182.1B23.624.9621.0%-1.27%
GILDGilead Sciences$153.5B18.045.2128.9%-1.46%
RVMDRevolution Medicines, Inc.$34.6B-30.62+3.14%
BIIBBiogen$29.0B22.442.9313.1%-1.15%
MRNAModerna$25.4B-8.99+3.22%
NBIXNeurocrine Biosciences Inc$15.9B33.245.5616.7%-0.48%
EXELExelixis, Inc.$13.1B16.685.6233.7%-1.04%
KRYSKrystal Biotech, Inc.$10.2B50.0226.3352.6%+1.68%
TECHBio-Techne$9.1B123.617.446.0%+5.36%
HALOHalozyme Therapeutics, Inc.$8.1B25.675.8222.7%-0.03%
IBRXImmunitybio, Inc.$7.7B-21.87+5.01%
RGENRepligen Corp$7.4B152.2710.086.6%-1.20%
KYMRKymera Therapeutics, Inc.$7.4B23.88+0.44%
PCVXVaxcyte, Inc.$7.4B-9688.00+1.57%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.